BRCA2 and cancer: It is worth noting that our results of olaparib resistance in different BRCA1 mutant cells due to EMI1 downregulation that were associated with high RAD51 levels are in line with previous results done either in BRCA1 mutant cancer cells [20] or BRCA2 mutant ones [29].